Status:
COMPLETED
A Study of the Alternative Administration of Ixabepilone and Vinflunine
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of the study is to test how vinflunine interacts with ixabepilone in the human body.
Eligibility Criteria
Inclusion
- ECOG status of 0-1
Exclusion
- Inability to tolerate venous access
- Brain mets
- Severe nerve damage
- ANC \<2,000/mm3
- Platelets \<100K
- Bilirubin \>= 1.5 times the IULN
- ALT/AST \>= 2.5 times the IULN
- Creatinine \<50 mL/min
- Prior treatment with vinflunine and/or ixabepilone
- Strong use of CYPP450 drugs
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00362830
Start Date
August 1 2006
End Date
September 1 2007
Last Update
September 19 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Miami Miller School Of Medicine
Miami, Florida, United States, 33136
2
The Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195